Explore every episode of the podcast Hematology CrossTalk
| Title | Pub. Date | Duration | |
|---|---|---|---|
| Beyond Diagnosis: The Evolving Role of Flow Cytometry in AML and MDS | 21 Sep 2026 | 00:15:55 | |
Welcome to the first episode of Hematology CrossTalk, a new podcast bringing together experts from across hematology to explore the challenges shaping clinical practice and laboratory diagnostics. Hosted by Dr. Gianluca Rotta (Waters™ Biosciences, formerly BD Biosciences), the episode features Prof. Francesco Buccisano and Dr. Vittorio Emanuele Muccio, bringing together clinical and laboratory expertise in flow cytometryand hematology. Prof. Francesco Buccisano is Associate Professor of Hematology at Tor Vergata University of Rome, Italy, and Director of Immunohematology and Transfusion Medicine at the Tor Vergata Polyclinic. He is an internationally recognized expert in flow cytometry and leads a reference center for the diagnosis and assessment of measurable residual disease (MRD) in AML. Dr. Vittorio Emanuele Muccio is a ClinicalPathology Specialist and Senior Biologist in the Flow Cytometry and Protein Diagnostics Unit at San Luigi Gonzaga University Hospital in Orbassano, Italy. His expertise includes diagnostic flow cytometry, oncohematology, immunophenotyping and MRD assessment, with a particular focus on the standardization and harmonization of flow cytometry and laboratory workflows. In this episode they explore the evolving role of flow cytometry in the diagnosis of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), highlighting the shift from morphology-based assessment to a more integrateddiagnostic approach. They discuss complex diagnostic cases, laboratory workflows and the importance of clear, standardized reporting. The discussion underscores how technology, standardization and collaboration can help improve patient care. Access the discussion highlights and discover the next episode: https://bit.ly/4xCrRcz All contents are and should be understood as informative in nature and do not discuss, endorse or recommend any specific test, technology, or clinical action. Supported by Waters™ Biosciences (formerly BD Biosciences). | |||